Entinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway

Histone deacetylase inhibitors (HDACi) are an emerging cancer therapy; however, their effect on natural killer (NK) cell-mediated anti-tumor responses remain unknown. Here, we evaluated the impact of a benzamide HDACi, entinostat, on human primary NK cells as well as tumor cell lines. Entinostat sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Idso, John M., Lao, Shunhua, Schloemer, Nathan J., Knipstein, Jeffrey, Burns, Robert, Thakar, Monica S., Malarkannan, Subramaniam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244011/
https://www.ncbi.nlm.nih.gov/pubmed/32499867
http://dx.doi.org/10.18632/oncotarget.27546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244011/
https://www.ncbi.nlm.nih.gov/pubmed/32499867
http://dx.doi.org/10.18632/oncotarget.27546

Ejemplares similares